Get the Stockscreener App
18.80
2.24%
-0.395
Overview
News
Price History
Option Chain
Financials
Why KVUE Down?
Discussions
Forecast
Dividend History
Kenvue Inc stock is traded at $18.80, with a volume of 12.71M.
It is down -2.24% in the last 24 hours and down -1.11% over the past month.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
See More
Previous Close:
$19.20
Open:
$19.04
24h Volume:
12.71M
Relative Volume:
0.64
Market Cap:
$36.12B
Revenue:
$15.29B
Net Income/Loss:
$1.62B
P/E Ratio:
22.30
EPS:
0.8433
Net Cash Flow:
$1.82B
1W Performance:
-1.37%
1M Performance:
-1.11%
6M Performance:
+1.96%
1Y Performance:
-11.46%
1-Day Range:
$18.73
$19.04
1-Week Range:
$18.65
$19.31
52-Week Range:
$14.02
$21.84
Kenvue Inc Stock (KVUE) Company Profile
Name
Kenvue Inc
Sector
Industry
Phone
908-874-1200
Address
1 KENVUE WAY, SUMMIT
Compare KVUE vs PG, UL, CL, CCL
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KVUE
Kenvue Inc
|
18.80 | 36.88B | 15.29B | 1.62B | 1.82B | 0.8433 |
PG
Procter Gamble Co
|
143.14 | 336.00B | 86.72B | 16.69B | 15.03B | 6.8375 |
UL
Unilever Plc Adr
|
61.35 | 133.70B | 56.67B | 6.96B | 7.39B | 3.1265 |
CL
Colgate Palmolive Co
|
90.53 | 73.30B | 20.80B | 2.22B | 3.77B | 2.5772 |
CCL
Colgate Palmolive Co
|
27.79 | 38.51B | 26.98B | 3.10B | 2.98B | 2.2492 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-26 | Downgrade | Jefferies | Buy → Hold |
| Oct-29-25 | Downgrade | Canaccord Genuity | Buy → Hold |
| Sep-26-25 | Upgrade | Rothschild & Co Redburn | Neutral → Buy |
| Apr-10-25 | Initiated | Redburn Atlantic | Neutral |
| Mar-24-25 | Initiated | Evercore ISI | In-line |
| Jan-06-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-12-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Sep-24-24 | Initiated | Jefferies | Buy |
| Sep-24-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-28-24 | Resumed | Citigroup | Neutral |
| Apr-11-24 | Initiated | Bernstein | Underperform |
| Apr-03-24 | Initiated | William Blair | Mkt Perform |
| Mar-01-24 | Resumed | Goldman | Neutral |
| Nov-17-23 | Initiated | Piper Sandler | Neutral |
| Sep-11-23 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-07-23 | Initiated | Canaccord Genuity | Buy |
| Sep-06-23 | Initiated | Argus | Hold |
| Aug-24-23 | Upgrade | Goldman | Neutral → Buy |
| Jul-25-23 | Initiated | Edward Jones | Buy |
| Jun-01-23 | Initiated | HSBC Securities | Hold |
| May-30-23 | Initiated | BofA Securities | Buy |
| May-30-23 | Initiated | Citigroup | Neutral |
| May-30-23 | Initiated | Deutsche Bank | Hold |
| May-30-23 | Initiated | Exane BNP Paribas | Neutral |
| May-30-23 | Initiated | Goldman | Neutral |
| May-30-23 | Initiated | JP Morgan | Overweight |
| May-30-23 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Initiated | UBS | Neutral |
View All
Kenvue Inc Stock (KVUE) Latest News
Kenvue’s $1.1 Billion Beauty Segment Faces Scrutiny as Neutrogena Draws Viral Backlash - TechStock²
Should Kenvue’s (KVUE) Stronger Q2 2026 Earnings Shift Investors’ View of Its Profitability Story? - simplywall.st
Kenvue stock holds near analyst targets as income appeal grows - AD HOC NEWS
Wealth Effects LLC Invests $3.38 Million in Kenvue Inc. $KVUE - MarketBeat
87,459 Shares in Kenvue Inc. $KVUE Acquired by HBK Sorce Advisory LLC - MarketBeat
Kenvue Inc. (NYSE:KVUE) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Alberta Investment Management Corp Acquires New Shares in Kenvue Inc. $KVUE - MarketBeat
Kimberly-Clark Appoints Suzana Blades as General Counsel Ahead of Kenvue Acquisition - Global Cosmetics News
The Technical Signals Behind (KVUE) That Institutions Follow - Stock Traders Daily
Kimberly-Clark Elevates Blades to GC Ahead of Kenvue Deal (1) - Bloomberg Law News
South Africa's Competition Tribunal Conditionally Approves Kimberly-Clark And Kenvue Deal - TradingView
Jim Cramer Said Kimberly-Clark Corporation (NYSE:KMB) + Kenvue Could Take On P&G – But Is He Right? - Yahoo Finance
Kenvue Inc. stock rises Thursday, outperforms market - MarketWatch
Kenvue options activity surges on bullish call bets ahead of merger news - Investing.com
Kimberly-Clark Names Suzana Blades General Counsel Ahead of Kenvue Deal - citybiz
Kimberly-Clark appoints Suzana Blades as senior vice president and general counsel - Mass Market Retailers
Y Intercept Hong Kong Ltd Acquires Shares of 1,055,367 Kenvue Inc. $KVUE - MarketBeat
San Luis Wealth Advisors LLC Buys New Stake in Kenvue Inc. $KVUE - MarketBeat
Handelsbanken Fonder AB Has $21.75 Million Position in Kenvue Inc. $KVUE - MarketBeat
Brookstone Capital Management Sells 193,541 Shares of Kenvue Inc. $KVUE - MarketBeat
Kenvue Q2 Deep Dive: Assessing Financial Metrics & Growth Prospects - TradingView
Kimberly-Clark: Temporary Headwinds, Strong Innovation And Kenvue Synergies Support A Buy - Seeking Alpha
Rep. Kevin Hern Sells Off Kenvue Inc. (NYSE:KVUE) Stock - MarketBeat
RBC Capital Sticks to Its Hold Rating for Kenvue, Inc. (KVUE) - The Globe and Mail
UBS Maintains Kenvue(KVUE.US) With Hold Rating, Cuts Target Price to $19 - moomoo.com
KVUE Maintained by UBS -- Price Target Lowered to $19.00 - GuruFocus
KENVUE INC. : UBS CUTS TARGET PRICE TO $19 FROM $20 - webull.com
UBS Adjusts Kenvue Price Target to $19 From $20, Maintains Neutral Rating - Moomoo
California Court Set To Decide Kenvue Successor Liability Question - Mealey's
HSBC Adjusts Price Target on Kenvue to $19 From $20, Maintains Hold Rating - Moomoo
Kenvue To Go Ex-Dividend On August 12th, 2026 With 0.21 USD Dividend Per Share - moomoo.com
Kenvue’s Beauty Sales Rise 5.1% as Neutrogena and OGX Drive Q2 Growth - Global Cosmetics News
Kenvue Inc (KVUE) Stock News Today - TradingKey
Kenvue Inc. stock falls Monday, underperforms market - MarketWatch
Kimberly-Clark gears up for major Kenvue overhaul - Chain Drug Review
Kenvue Inc. Stock 12‑Month Price Target Cut to $19.4, Implies 1% Upside - TradingView
Kimberly-Clark plans major shakeup after Kenvue deal - Mass Market Retailers
Kenvue Q2: Skin Health & Beauty Net Sales Rise 5.1% - Happi | Household And Personal Products Industry
Jacobs & Co. CA Has $1.83 Million Stake in Kenvue Inc. $KVUE - MarketBeat
Does Stronger Earnings And A Higher Dividend Change The Bull Case For Kenvue (KVUE)? - simplywall.st
Beacon Investment Advisory Services Inc. Lowers Position in Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc. (KVUE) Stock Forecasts - finance.yahoo.com
Kenvue Inc. $KVUE Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Wall Street Zen Downgrades Kenvue (NYSE:KVUE) to Hold - MarketBeat
Kenvue Inc (KVUE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Sio Capital Management, LLC's Kenvue Inc(KVUE) Holding History - GuruFocus
How Reddit and Wall Street See Kenvue as Buyout Nears - Yahoo Finance
Janus Henderson Group PLC Buys 110,155 Shares of Kenvue Inc. $KVUE - MarketBeat
Kenvue Posts Higher 2Q Profit, Sales as Turnaround Continues - Moomoo
DWS Global Income Builder Fund's Kenvue Inc(KVUE) Holding History - GuruFocus
Kenvue (NYSE:KVUE) Posts Earnings Results, Misses Expectations By $0.01 EPS - MarketBeat
Kenvue Inc Stock (KVUE) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.61%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):